Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia

PHASE3RecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

April 19, 2024

Primary Completion Date

November 4, 2025

Study Completion Date

August 1, 2026

Conditions
DyslipidemiaType 2 Diabetes
Interventions
DRUG

CMG190303(Dapagliflozin/Rosuvastatin)

0-8 week: Dapagliflozin 10mg and Rosuvastatin 5mg 8-16 week: Dapagliflozin 10mg and Rosuvastatin 10mg 16-24 week: Dapagliflozin 10mg and Rosuvastatin 20mg

DRUG

Comparator 1: Dapagliflozin/Rosuvastatin placebo

0-24 week: Dapagliflozin 10mg and Rosuvastatin placebo

DRUG

Rosuvastatin/Dapagliflozin placebo

0-8 week: Dapagliflozin placebo and Rosuvastatin 5mg 8-16 week: Dapagliflozin placebo and Rosuvastatin 10mg 16-24 week: Dapagliflozin placebo and Rosuvastatin 20mg

Trial Locations (24)

10475

RECRUITING

Myongji Hospital, Goyang-si

11923

RECRUITING

Hanyang University Medical Center, Guri-si

13496

RECRUITING

Bundang CHA medical center, Seongnam

13620

RECRUITING

Seoul National University Bundang Hospital, Seongnam

14068

RECRUITING

Hallym university sungsim medical center, Anyang

14754

RECRUITING

Buchon sejong hospital, Buchon

16499

RECRUITING

Ajou University Hospital, Suwon

16995

RECRUITING

Yongin Severance Hospital, Yongin-si

22332

RECRUITING

Inha university hospital, Inchon

26426

RECRUITING

Wonju serverance christian hospital, Wŏnju

31151

RECRUITING

Soonchunhyang cheonan university hospital, Cheonan

35233

RECRUITING

Daejeon eulji medical center, eulji university, Daejeon

42601

RECRUITING

Keimyung University Dongsan Medical Center, Daegu

48108

RECRUITING

Inje university heaundea paik hospital, Busan

54538

RECRUITING

Wonkwang university hospital, Iksan

54907

RECRUITING

Chonbuk National University Hospital, Jeonju

61453

RECRUITING

Chosun University Hospital, Gwangju

01830

RECRUITING

Nowon eulji medical center, eulji university, Seoul

02841

RECRUITING

Korea University ANAM Hospital, Seoul

03722

RECRUITING

Severance hospital, Seoul

05278

RECRUITING

Kyung hee university hospital at gangdong, Seoul

06591

RECRUITING

The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul

07441

RECRUITING

Hallym university gangnam medical center, Seoul

08308

RECRUITING

Korea University Guro Hospital, Seoul

Sponsors
All Listed Sponsors
lead

CMG Pharmaceutical Co. Ltd

INDUSTRY

NCT06772168 - Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia | Biotech Hunter | Biotech Hunter